June 28, 2024
5 min watch
Save
VIDEO: CGM can now benefit pregnant women with type 1 diabetes
Issue: August 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about use of continuous glucose monitoring during pregnancy for women with type 1 diabetes.
Gavin is chief medical officer at Healing Our Village, clinical professor at Emory University. Powe is an endocrinologist at Massachusetts General Hospital and associate professor of medicine and obstetrics and gynecology at Harvard Medical School.
The experts discuss why CGM has just recently been approved for use in this population and what benefits it can bring.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Gavin reports no relevant financial disclosures. Powe reports research funding from Dexcom.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.